Try Ask OE! Our NEW Advanced AI Enabled Search
Dive into the Largest Database of
Musculoskeletal Evidence
ACE Reports.
Make a selection below to explore our full database of 5 results matching: "J Zanchetta"
ACE Reports
(5 Reports)
ACE Reports
Our Al driven High Impact metric predicts an article's future number of citations by considering the content of the article.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Open Advanced Search
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Metabolic Disorders
Denosumab is superior to alendronate for improving cortical bone porosity post-menopause
Bone. 2014 Feb;59:173-9. doi: 10.1016/j.bone.2013.11.016. Epub 2013 Nov 22.
Denosumab is superior to alendronate for improving cortical bone porosity post-menopause
Bone. 2014 Feb;59:173-9. doi: 10.1016/j.bone.2013.11.016. Epub 2013 Nov 22.
Metabolic Disorders
WCO-IOF: Changes with QCT, DXA, and TBS between denosumab, alendronate, & placebo
WCO-IOF: Changes with QCT, DXA, and TBS between denosumab, alendronate, & placebo
Metabolic Disorders
Parathyroid Hormone effective in fracture prevention in postmenopausal osteoporotic women
Ann Intern Med. 2007 Mar 6;146(5):326-39
Parathyroid Hormone effective in fracture prevention in postmenopausal osteoporotic women
Ann Intern Med. 2007 Mar 6;146(5):326-39
General Orthopaedics
Denosumab reduces risk of fractures in post-menopausal women
N Engl J Med. 2009 Aug 20;361(8):756-65. Epub 2009 Aug 11.
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Denosumab reduces risk of fractures in post-menopausal women
N Engl J Med. 2009 Aug 20;361(8):756-65. Epub 2009 Aug 11.
Metabolic Disorders
Tibolone reduces fracture risk in osteoporotic women but increases stroke risk
N Engl J Med. 2008 Aug 14;359(7):697-708
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Tibolone reduces fracture risk in osteoporotic women but increases stroke risk
N Engl J Med. 2008 Aug 14;359(7):697-708